Medtronic PLC (MDT) is seeing substantial changes in its stock holdings across numerous investment firms. Trivium Point Advisory, Central Securities Corp and First Financial Bankshares are among companies that increased their positions, while firms like Primecap Management, Intech Investment Management, and American Century Companies trimmed their holdings. Significant positions are held by DNB Asset Management, Harvest Portfolios Group, and the American Pension Fund, all with stakes valued in millions of dollars. Medtronic's performance has received a mixed response, with several firms, such as Dakota Wealth Management and Advisors Capital Management, expanding their holdings and firms like Pekin Hardy Strauss selling shares. It remains a good investment with an 'Average Rating of Moderate Buy' as reported. The company's diabetes unit, MiniMed, is heading a healthy IPO, increasing investor interest. However, there has been bearish options activity despite the company’s long-term growth outlook. Furthermore, the company reported strong third-quarter fiscal results, showing the highest enterprise revenue growth in 10 quarters. Additionally, the company plans to acquire CathWorks, demonstrating strategic advancements. Overall, Medtronic presents a rich, mixed investment profile with potential growth and varying market responses.
Medtronic Plc MDT News Analytics from Thu, 12 Jun 2025 07:00:00 GMT to Sat, 28 Feb 2026 14:51:55 GMT -
Rating 6
- Innovation 8
- Information 7
- Rumor -3
